Goodwin advised The Brydon Group on its investment. Renesan and Visonex announced a strategic combination of their businesses that will offer customers a flexible and secure...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Appleby advised Alvarium Investments on the deal. Seward & Kissel represented Tiedemann Advisors and TIG Advisors. Homburger advised Tiedemann Group and its Switzerland-based...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Neuberger Berman on the deal. Neuberger Berman announced its fifth global private equity secondary fund, NB Secondary Opportunities Fund V LP (“SOF V”). SOF...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised North Island Ventures on the deal. North Island Ventures announced the closing of its NIV Fund II with $125 million in commitments. With this...
You must be a Standard 1 Year member to access this content.
Goodwin advised Serena Ventures on the deal. Serena Ventures announced the formation of its inaugural fund, which closed with $111 million in commitments. The fund invests in...
You must be a Standard 1 Year member to access this content.
Debevoise & Plimpton has advised Global Atlantic Financial Group on the deal, while Simpson Thacher advised KKR on the deal. Goodwin advised Drawbridge Realty. KKR, a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised G Squared Ascend I on the deal. Latham & Watkins represented Transfix. G Squared Ascend I (NYSE: GSQD), a special purpose acquisition company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Vascular Biogenics Ltd. on the deal. Vascular Biogenics Ltd. (“VBL Therapeutics” or the “Company”) (NASDAQ: VBLT) announced the closing of its underwritten public offering...
You must be a Standard 1 Year member to access this content.
